English

DiaGenic ASA: Financial calendar for 2014

Report this content

Financial calendar for 2014:

  • 4thquarter results 2013: 20 February 2014

  • 1stquarter results 2014: 15 May 2014

  • Annual General Meeting: 22 May 2014

  • 2ndquarter results 2014: 21 August 2014

  • 3rdquarter results 2014: 6 November 2014

Contact:

Paul de Potocki, Chief Executive Officer

Telephone: 47 2324 8950

e-mail: paul.depotocki@diagenic.com

Ruben Ekbråten, Chief Financial Officer

Telephone: 47 2324 8950

e-mail: ruben.ekbraten@diagenic.com

About DiaGenic ASA

DiaGenic is an innovative Norwegian diagnostic company that seeks to create value for patients, partners and investors by developing innovative and patient friendly in vitro diagnostic (IVD) products for early detection of diseases. The company’s proprietary concept implies that a disease evokes systemic responses in the blood unique for the disease, and which can be measured by using a blood sample. DiaGenic is a world leader in identifying gene expression signatures in blood and is focused on the development of IVD biomarker products in the field of Alzheimer’s disease. The company protects its technology through an extensive patent portfolio. DiaGenic is listed on the Oslo Stock Exchange. For more information please visit: www.diagenic.com

Subscribe